Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Reducing uncertainty in risk assessment by using specific knowledge to replace default options

R O McClellan1

  • 1Chemical Industry Institute of Toxicology, Research Triangle Park, North Carolina 27709, USA.

Drug Metabolism Reviews
|February 1, 1996
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

I-131-LABELED ROSE BENGAL DYE BLOOD CLEARANCE AS A LIVER FUNCTION TEST IN SHEEP. HW-76000.

HW-SA [reports]. U.S. Atomic Energy Commission·2014
Same author

COMPARATIVE TOXICITY OF SR-90, RA-226, AND PU-239. HW-76000.

HW-SA [reports]. U.S. Atomic Energy Commission·2014
Same author

ACUTE TOXICITY OF NP-237 AND ITS RELATIONSHIP TO LIVER FUNCTION IN SHEEP. HW-76000.

HW-SA [reports]. U.S. Atomic Energy Commission·2014
Same author

METABOLISM OF PM-147 AND CE-144 IN MINIATURE SWINE. HW-76000.

HW-SA [reports]. U.S. Atomic Energy Commission·2014
Same author

BIOLOGICAL EFFECTS OF SR-90 IN MINIATURE SWINE-THIRD PROGRESS REPORT. HW-76000.

HW-SA [reports]. U.S. Atomic Energy Commission·2014
Same author

CHANGES IN CA-45-SR-90 METABOLISM WITH AGE IN YOUNG MINIATURE SWINE. HW-76000.

HW-SA [reports]. U.S. Atomic Energy Commission·2014
Same journal

Humanized mouse models for drug metabolism and drug transport: a systematic review.

Drug metabolism reviews·2026
Same journal

Drug transporters in drug disposition - highlights from the year 2025.

Drug metabolism reviews·2026
Same journal

Herbal supplements and anti-tuberculosis therapy: unlocking hidden interactions for better multidrug-resistant tuberculosis management.

Drug metabolism reviews·2026
Same journal

Identification and characterization of a novel aldehyde metabolite of WIN18,446 and associated WIN18,446-ALDH1A2 protein adducts using mass spectrometry.

Drug metabolism reviews·2026
Same journal

Pharmacomicrobiomics in precision pharmacotherapy: bidirectional microbial-drug interactions as a key determinant of therapeutic response.

Drug metabolism reviews·2026
Same journal

Population pharmacokinetics of levofloxacin: a systematic review.

Drug metabolism reviews·2026
See all related articles

Developing specific scientific data on chemical mechanisms of action is crucial for accurate human cancer risk assessment, moving beyond default options. This approach enhances data acceptance and risk evaluation efficiency.

Area of Science:

  • Toxicology and Carcinogenesis
  • Risk Assessment
  • Molecular Biology

Background:

  • Current human cancer risk assessments often rely on default assumptions.
  • There is a growing need for specific scientific information, particularly on chemical mechanisms of action.
  • Advancements in cellular and molecular techniques offer new avenues for data generation.

Purpose of the Study:

  • To advocate for the development and use of specific scientific data in human cancer risk assessment.
  • To explore the effectiveness and acceptance of mechanistic data over default options.
  • To improve the efficiency of obtaining and utilizing such data for regulatory purposes.

Main Methods:

  • Framing mechanistic data within an exposure-dose-response paradigm.

Related Experiment Videos

  • Linking molecular and cellular observations to relevant human health endpoints (cancer).
  • Ensuring mechanistic data is connected to realistic human exposure scenarios and tissue doses.

    • Main Results:

    • Four examples demonstrate the value of mechanistic data, largely from the CIIT research program.
    • Mechanistic data, when linked to realistic exposures, enhances the value of molecular and cellular observations for risk assessment.
    • Qualitative decisions, like the alpha 2u-globulin nephropathy case, highlight species-specific differences and their implications for human risk assessment.

    Conclusions:

    • Specific mechanistic data, framed within an exposure-dose-response paradigm and linked to realistic exposures, is essential for accurate human cancer risk assessment.
    • Quantitative differences in chemical potency across species are critical for human risk evaluation, necessitating a move beyond simple classification systems.
    • Continued use of laboratory animals is rational, provided species differences are understood and capitalized upon to refine human risk assessments.